• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Babylon Holdings Limited filed SEC Form 8-K: Other Events

    8/11/23 5:01:17 PM ET
    $BBLN
    Medical/Nursing Services
    Health Care
    Get the next $BBLN alert in real time by email
    0001866390 false 0001866390 2023-08-08 2023-08-08 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

     

    FORM 8-K

     

     

     

    CURRENT REPORT

    Pursuant to Section 13 or 15(d)

    of the Securities Exchange Act of 1934

     

    August 8, 2023

    Date of Report (date of earliest event reported)

     

     

     

    Babylon Holdings Limited

    (Exact name of registrant as specified in its charter)

     

     

     

    Bailiwick of Jersey, Channel Islands

    (State or other jurisdiction of

    incorporation)

    001-40952

    (Commission File Number)

    98-1638964

    (IRS Employer Identification No.)

         
    1 Knightsbridge Green, London,
    United Kingdom
      SW1X 7QA
    (Address of principal executive
    offices)
      (Zip Code)
    (+44 (0)) 20 7100 0762
    (Registrant's telephone number, including area code)
     
    Not Applicable
    (Former name or former address, if changed since last report)

     

     

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    ¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    ¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Securities registered pursuant to Section 12(g) of the Act:
     
    Title of each class Trading Symbol(s) Name of each exchange on which registered
    Class A ordinary shares, par value $0.001056433113 per share BBLNF OTC Pink Market

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

     

    Emerging growth company    x

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   ¨

     

     

     

     

     

     

    Item 8.01 Other Events.

     

    Certain affiliates of Centene Corporation (the “Centene Affiliates” and, together, “Centene”) are parties to the following agreements (collectively, the “Babylon Contracts”) with Babylon Healthcare, Inc. and/or its affiliates (the “Babylon Contracting Parties”), each of which is a subsidiary of Babylon Holdings Limited (“Babylon” or the “Company”):

     

    BABYLON AGREEMENTS

     

    All as may have been amended:

     

    Name of Agreement Centene Affiliate Parties Effective Date
    Babylon Capitation Agreement Home State Health Plan, Inc. 10/01/20
    Participation Provider Agreement Home State Health Plan, Inc., California Health & Wellness Plan, Health Net of California, Inc., and Health Net Community Solutions, Inc., Iowa Total Care, SilverSummit HealthPlan, Inc., Oklahoma Complete Health, Inc., WellCare of Oklahoma, Inc., WellCare Health Insurance Co. of Oklahoma, Inc. and Centene Venture Company Indiana, Coordinated Care Corporation, d/b/a Managed Health Services. 04/01/20

    Participating Provider Agreement

    (Babylon Healthcare of TX, LLC)

    Celtic Ins. Co., on behalf of itself and any of its Affiliates that choose to participate 01/01/23

    Participating Provider Agreement

    (Babylon Healthcare, PLLC)

    Celtic Ins. Co., on behalf of itself and any of its Affiliates that choose to participate 01/01/23
    Value-Based Program Participating Provider Agreement Home State Health Plan, Inc. 01/01/22
    Participating Provider Agreement Nebraska Total Care, Inc. 01/01/23
    Value-Based Program Participating Provider Agreement Magnolia Health Plan, Inc. 10/01/21
    Participating Provider Agreement Buckeye Community Health Plan, Inc. 01/01/23
    Value-Based Program Participating Provider Agreement Iowa Total Care, Inc. 01/01/22
    Value-Based Program Participating Provider Agreement Granite State Health Plan, Inc. 01/01/23
    Participating Provider Agreement Peach State Health Plan, Inc. 10/01/21
    Fidelis Care Standard Health Services Agreement 20 New York Quality Healthcare Corporation d/b/a Fidelis Care

    01/01/20

     

    Value-Based Program Participating Provider Agreement Peach State Health Plan, Inc. 10/1/21

     

    On August 4, 2023, Centene, on behalf of the Centene Affiliates, delivered written notice (the "Non-Renewal Notice") to the Babylon Contracting Parties that the Centene Affiliates do not intend to renew the Babylon Contracts or any other agreements between Centene and the Babylon Contracting Parties (collectively, the "Centene Agreements"), and that Centene reserved their rights to terminate the respective Centene Agreements to which they are parties.

     

    On August 7, 2023, the Company announced that the transaction proposed by AlbaCore Capital LLP (“AlbaCore”) and MindMaze Group SA (“MindMaze”) for a business combination of the Company’s core operating subsidiaries with MindMaze, previously announced on June 23, 2023 (the “Previously Proposed Transaction”), will not proceed, and that the Company was exiting its core US business.

     

     

     

     

    Following this disclosure, on August 8, 2023, the Babylon Contracting Parties received formal written notification (the "Termination Notice") from Centene of immediate termination for all Babylon Contracts, but excluding the following three agreements with Babylon's IPA Business (as amended from time to time): (a) the California Plan-to-Plan Agreement between Meritage Health Plan and Health Net of California, Inc., with an original effective date June 1, 2021; (b) the Provider Participation Agreement between Meritage Medical Network (f/k/a Marin IPA) and Health Net of California, Inc., with an original effective date of January 1, 2011; and (c) the Provider Participation Agreement between Meritage Medical Network (f/k/a First Choice Medical Group) and Health Net of California, Inc., with an original effective date of November 1, 2014.

     

    The Centene Agreements, collectively, are material to the Company and relate to the provision of healthcare services to Centene's patients and members, representing 48.1% of the Company's revenue in the year ended December 31, 2022. Babylon has not identified any material early termination penalties as a result of the receipt of the Non-Renewal Notice or Termination Notice. In addition to the Centene Agreements, Centene has a material relationship with Babylon as a Babylon Class A ordinary shareholder.

     

     

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

    Date: August 11, 2023

     

      Babylon Holdings Limited
         
      By: /s/ David Humphreys
      Name: David Humphreys
      Title: Chief Financial Officer

     

     

     

    Get the next $BBLN alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $BBLN

    DatePrice TargetRatingAnalyst
    3/16/2023Buy → Neutral
    BTIG Research
    1/5/2023$4.00 → $20.00Buy
    BTIG Research
    6/23/2022$2.00Neutral
    BofA Securities
    4/28/2022$5.50Hold
    Berenberg
    1/12/2022$9.00Buy
    Deutsche Bank
    12/7/2021$8.00Neutral
    Citigroup
    12/2/2021$14.00Buy
    Canaccord Genuity
    12/2/2021$9.00Hold
    Jefferies
    More analyst ratings

    $BBLN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4 filed by Vnv Global Ab (Publ)

      4 - Babylon Holdings Ltd (0001866390) (Issuer)

      6/30/23 4:18:26 PM ET
      $BBLN
      Medical/Nursing Services
      Health Care
    • SEC Form 4 filed by Vnv Global Ab (Publ)

      4 - Babylon Holdings Ltd (0001866390) (Issuer)

      6/28/23 5:29:39 PM ET
      $BBLN
      Medical/Nursing Services
      Health Care
    • SEC Form 4 filed by Vnv (Cyprus) Ltd

      4 - Babylon Holdings Ltd (0001866390) (Issuer)

      6/26/23 6:25:34 PM ET
      $BBLN
      Medical/Nursing Services
      Health Care

    $BBLN
    SEC Filings

    See more
    • Babylon Holdings Limited filed SEC Form 8-K: Other Events

      8-K - Babylon Holdings Ltd (0001866390) (Filer)

      8/31/23 5:18:08 PM ET
      $BBLN
      Medical/Nursing Services
      Health Care
    • Babylon Holdings Limited filed SEC Form 8-K: Other Events

      8-K - Babylon Holdings Ltd (0001866390) (Filer)

      8/11/23 5:01:17 PM ET
      $BBLN
      Medical/Nursing Services
      Health Care
    • SEC Form NT 10-Q filed by Babylon Holdings Limited

      NT 10-Q - Babylon Holdings Ltd (0001866390) (Filer)

      8/10/23 5:21:19 PM ET
      $BBLN
      Medical/Nursing Services
      Health Care

    $BBLN
    Press Releases

    Fastest customizable press release news feed in the world

    See more

    $BBLN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Babylon Proceeds With Previously Announced Transaction and Announces the Receipt of Continued Listing Standards Notice from NYSE and Upcoming Delisting

      Babylon Holdings Limited (the "Company" or "Babylon") (NYSE:BBLN) previously announced in its June 23, 2023 press release that the Company has received a proposal from AlbaCore Capital LLP ("AlbaCore") and MindMaze Group SA ("MindMaze") pursuant to which core operating subsidiaries of the Company would be transferred to MindMaze (the "Proposed Transaction"). The closing of the Proposed Transaction is expected in July 2023 and is subject to agreed documentation, various conditions and appropriate approvals, if required. The Proposed Transaction will not provide for any payment to the Company's Class A ordinary shareholders or other equity instrument holders, as AlbaCore will be exercising ri

      6/28/23 4:30:00 PM ET
      $BBLN
      Medical/Nursing Services
      Health Care
    • Babylon Announces Update on Take Private Proposal

      After a thorough exploration of strategic alternatives, Babylon Holdings Limited (NYSE:BBLN) (including its subsidiaries, "Babylon") is pleased to provide an update on the recapitalization transaction, previously announced on May 10, following receipt of a proposal from AlbaCore Capital LLP on behalf of certain of its affiliates ("AlbaCore") and MindMaze Group SA ("MindMaze"), and share that Babylon has selected the previously announced take private proposal from the options considered. The proposal strongly positions Babylon to accelerate its core mission – to make high quality healthcare more accessible and affordable by combining the most cutting-edge technology with the best medical ex

      6/23/23 6:00:00 AM ET
      $BBLN
      Medical/Nursing Services
      Health Care
    • Babylon Reports Q1 2023 Financial Results

      Babylon Holdings Limited (NYSE:BBLN) ("Babylon" or the "Company") today announced its financial and operating results for the first quarter ended March 31, 2023. First Quarter Financial Results Comparison of the following financial results for the three months ended March 31, 2023, to the three months ended March 31, 2022: Total revenue was $311.1 million compared to $266.4 million, a 1.2x year-over-year increase of $44.7 million. This was primarily due to the growth in VBC revenue, which increased by 17% year-over-year to $287.5 million in Q1 2023. Net loss totaled $63.2 million, a (20.3)% Net loss margin compared to Net loss of $29.1 million, a (10.9)% Net loss margin in Q1 2022

      5/10/23 6:01:00 AM ET
      $BBLN
      Medical/Nursing Services
      Health Care
    • Babylon downgraded by BTIG Research

      BTIG Research downgraded Babylon from Buy to Neutral

      3/16/23 7:14:08 AM ET
      $BBLN
      Medical/Nursing Services
      Health Care
    • BTIG Research reiterated coverage on Babylon with a new price target

      BTIG Research reiterated coverage of Babylon with a rating of Buy and set a new price target of $20.00 from $4.00 previously

      1/5/23 9:37:21 AM ET
      $BBLN
      Medical/Nursing Services
      Health Care
    • BofA Securities initiated coverage on Babylon with a new price target

      BofA Securities initiated coverage of Babylon with a rating of Neutral and set a new price target of $2.00

      6/23/22 9:05:00 AM ET
      $BBLN
      Medical/Nursing Services
      Health Care

    $BBLN
    Financials

    Live finance-specific insights

    See more
    • Babylon Reports Q1 2023 Financial Results

      Babylon Holdings Limited (NYSE:BBLN) ("Babylon" or the "Company") today announced its financial and operating results for the first quarter ended March 31, 2023. First Quarter Financial Results Comparison of the following financial results for the three months ended March 31, 2023, to the three months ended March 31, 2022: Total revenue was $311.1 million compared to $266.4 million, a 1.2x year-over-year increase of $44.7 million. This was primarily due to the growth in VBC revenue, which increased by 17% year-over-year to $287.5 million in Q1 2023. Net loss totaled $63.2 million, a (20.3)% Net loss margin compared to Net loss of $29.1 million, a (10.9)% Net loss margin in Q1 2022

      5/10/23 6:01:00 AM ET
      $BBLN
      Medical/Nursing Services
      Health Care
    • Babylon Announces First Quarter 2023 Earnings Conference Call

      Babylon (NYSE:BBLN) (the "Company") today announced it will host a conference call to review its first quarter financial results on Wednesday, May 10, 2023, at 8:00 AM Eastern Time. A press release announcing the results will be issued prior to the conference call on Wednesday, May 10, 2023. To participate in the live conference call and webcast, please dial (877) 407-7994 for U.S. participants, 0 800 756 3429 for U.K. participants or +1 215-268-9868 for international participants. Alternatively, you can visit the "News & Events" section of https://ir.babylonhealth.com to access the live webcast. On this page, you can also find a "Call me" link for instant telephone access to the event, w

      4/19/23 6:00:00 AM ET
      $BBLN
      Medical/Nursing Services
      Health Care
    • Babylon Reports Another Strong Year Exceeding Guidance, and Accelerates Expected Adjusted EBITDA Profitability to Mid-2024

      Revenue grew 3.5x YoY, to $1.11 billion, exceeding guidance Cost of Care Delivery (COCD) Margin in the U.K. already profitable1, with U.S. Clinical services also expecting COCD profitability in early 2023 Key U.S. VBC contracts delivered profitable Medical Margins2 in their first year Monthly Adjusted EBITDA of $(16.3) million for Q4 2022 beating guidance of $(18) million Adjusted EBITDA profitability expected in mid-2024, significantly earlier than previous guidance Commercial VBC revenue substantially increased with recent launch of Ambetter digital-first service across 6 states Babylon Holdings Limited (NYSE:BBLN) ("Babylon" or the "Company") today announced its financial an

      3/9/23 6:00:00 AM ET
      $BBLN
      Medical/Nursing Services
      Health Care

    $BBLN
    Leadership Updates

    Live Leadership Updates

    See more
    • Babylon Appoints David Humphreys as Chief Financial Officer

      Babylon Holdings Limited (NYSE:BBLN) ("Babylon" or the "Company"), one of the world's fastest growing digital healthcare companies, announces that David Humphreys will be appointed as the Company's new Chief Financial Officer. Mr. Humphreys has been at Babylon for nearly two years in the role of Finance Director, with overall responsibility for building and scaling Babylon's finance function. Formerly, he was US-based as a Silicon Valley and New York Partner with PwC for over 20 years, working with Boards and leaders of fast-moving, rapid-growth companies including Tesla and Facebook to which he provided accounting consulting, transaction, IPO, M&A and auditing services to ensure complianc

      8/23/22 5:10:00 PM ET
      $BBLN
      Medical/Nursing Services
      Health Care

    $BBLN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13D/A filed by Babylon Holdings Limited (Amendment)

      SC 13D/A - Babylon Holdings Ltd (0001866390) (Subject)

      6/29/23 5:26:01 PM ET
      $BBLN
      Medical/Nursing Services
      Health Care
    • SEC Form SC 13G/A filed by Babylon Holdings Limited (Amendment)

      SC 13G/A - Babylon Holdings Ltd (0001866390) (Subject)

      2/14/23 11:54:33 AM ET
      $BBLN
      Medical/Nursing Services
      Health Care
    • SEC Form SC 13G/A filed by Babylon Holdings Limited (Amendment)

      SC 13G/A - Babylon Holdings Ltd (0001866390) (Subject)

      11/14/22 4:08:50 PM ET
      $BBLN
      Medical/Nursing Services
      Health Care